Outcome of PMID:18400723 |
Pca Type |
Index Name |
Unit |
Stratification |
Effect Index (crude) |
P-value (crude) |
Effect Index (Adjusted) |
P-value (Adjusted) |
Advanced PCa | Menaquinones | μg/day | Continuous | NA | NA | 0.81,0.67,0.99 | NA | Advanced PCa | Menaquinones | μg/day | Q1(<26) | NA | NA | 1.0,Ref | NA | Advanced PCa | Menaquinones | μg/day | Q2(26 –35) | NA | NA | 0.79,0.47,1.34 | NA | Advanced PCa | Menaquinones | μg/day | Q3(35– 46) | NA | NA | 0.67,0.36,1.25 | NA | Advanced PCa | Menaquinones | μg/day | Q4(≥46) | NA | NA | 0.37,0.16,0.88 | NA | Total PCa | Menaquinones | μg/day | Continuous | NA | NA | 0.94,0.84,1.05 | NA | Total PCa | Menaquinones | μg/day | Q1(<26) | NA | NA | 1.0,Ref | NA | Total PCa | Menaquinones | μg/day | Q2(26 –35) | NA | NA | 0.76,0.53,1.08 | NA | Total PCa | Menaquinones | μg/day | Q3(35– 46) | NA | NA | 0.71,0.47,1.06 | NA | Total PCa | Menaquinones | μg/day | Q4(≥46) | NA | NA | 0.65,0.39,1.06 | NA | Advanced PCa | Phylloquinone | μg/day | Continuous | NA | NA | 0.99,0.95,1.03 | NA | Advanced PCa | Phylloquinone | μg/day | Q1(<71) | NA | NA | 1.0,Ref | NA | Advanced PCa | Phylloquinone | μg/day | Q2(71–94) | NA | NA | 1.11,0.66,1.88 | NA | Advanced PCa | Phylloquinone | μg/day | Q3(94 –124) | NA | NA | 0.97,0.56,1.71 | NA | Advanced PCa | Phylloquinone | μg/day | Q4(≥124) | NA | NA | 0.84,0.46,1.56 | NA | Total PCa | Phylloquinone | μg/day | Continuous | NA | NA | 1.00,0.98,1.03 | NA | Total PCa | Phylloquinone | μg/day | Q1(<71) | NA | NA | 1.0,Ref | NA | Total PCa | Phylloquinone | μg/day | Q2(71–94) | NA | NA | 0.88,0.62,1.25 | NA | Total PCa | Phylloquinone | μg/day | Q3(94 –124) | NA | NA | 0.91,0.63,1.31 | NA | Total PCa | Phylloquinone | μg/day | Q4(≥124) | NA | NA | 1.02,0.70,1.48 | NA |